[HTML][HTML] Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study
IR Rosa, CP Barbosa, CA Ferrandez… - JBRA Assisted …, 2023 - ncbi.nlm.nih.gov
Objective Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study.
IR Rosa, CP Barbosa, CA Ferrandez… - JBRA Assisted …, 2023 - europepmc.org
Objective Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study
RI Ribeiro, BC Parente, CA Ferrandez… - JBRA Assisted …, 2023 - search.proquest.com
Objective Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
[PDF][PDF] Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study
IR Rosa, CP Barbosa, CA Ferrandez, BDB Sonoda… - researchgate.net
Objective: Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study
IR Rosa, CP Barbosa, CA Ferrandez… - JBRA assisted …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study
I Rosa, C Barbosa, C Ferrandez, B Sonoda… - JBRA, 2023 - iris.unipa.it
Objective: Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
[PDF][PDF] Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study
IR Rosa, CP Barbosa, CA Ferrandez, BDB Sonoda… - academia.edu
Objective: Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
[PDF][PDF] Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study
IR Rosa, CP Barbosa, CA Ferrandez, BDB Sonoda… - academia.edu
Objective: Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …
Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study.
IR Rosa, CP Barbosa, CA Ferrandez… - JBRA Assisted …, 2023 - europepmc.org
Objective Single nucleotide variants have been implicated in the response to fertility
treatment and a pharmacogenomic approach may help to customize therapy based on …
treatment and a pharmacogenomic approach may help to customize therapy based on …